Facilities

Indian CDMO denies manufacturing drug, contract testing lab pulled up for deficiencies, and lessons learned from Sanofi’s warning letter.

How do you design, refine, and optimize novel GLP-1 drugs that could improve patient experiences? With a computer, of course.

The rocket-fueled dreams of a young engineer applied to the cleanroom industry.

Claus Zieler reflects on his time at Astellas and his role at EFPIA.

The Alliance for RTU has been founded to accelerate and improve manufacturing quality, consistency, and regulatory efficiency.

Civica Rx is approaching generic drug manufacturing using a nonprofit model – and it’s working. We get the story behind their facility in Petersburg.

Do you have systems in place to negate power fluctuations or failures? Fill-Finish CDMO Vetter shares tips based on their experiences.

Why GLP-1 anti-obesity drugs are taking the market by storm.

The benefits of closed processing are well-documented, but what about the sustainability angle?

From renewable energy to bicycle schemes and more; here are just a few examples of how a pharma business can be more sustainable.